Breast cancer was the second most frequent tumor, with 7 cases (20%) in mutation carriers (3 in MLH1 and 2 in MSH2 and MSH6) and 29 cases (80%) in noncarriers (Table 3 and Fig 2). Here, MSH2 is linked to breast carcinoma.